Market research
MBX.TO Microbix Biosystems Inc
TO CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 0.4
- Dividend yield
- Not available
- Beta
- 0.54
Profile
Company facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- CA59501P1045
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 0.4
- Dividend yield
- Not available
- Beta
- 0.54
About
About Microbix Biosystems Inc
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the MBX.TO discussion.
5 years, 6 months ago
Microbix Biosystems Inc is currently in a long term uptrend where the price is trading 8.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.2.
Microbix Biosystems Inc's total revenue rose by 54.3% to $3M since the same quarter in the previous year.
Its net income has increased by 122.4% to $131K since the same quarter in the previous year.
Finally, its free cash flow fell by 532.5% to $-462K since the same quarter in the previous year.
Based on the above factors, Microbix Biosystems Inc gets an overall score of 4/5.